Efavirenz

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $1.3661

No Shortage Tier 1: 19.8% 5 Manufacturers 8 ANDAs

Covered Lives

Generic Manufacturers

AUROBINDO PHARMA LTDCIPLA LTDHETERO LABS LTD UNIT IIIMACLEODS PHARMACEUTICALS LTDPHARMOBEDIENT CONSULTING LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Efavirenz drfinder.aiFind doctors who prescribe Efavirenz rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Efavirenz

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.